Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting STING in cancer: Challenges and emerging opportunities
Kexin Zhao, Jiaojiao Huang, Yue Zhao, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 6, pp. 188983-188983
Closed Access | Times Cited: 23

Showing 23 citing articles:

Clinical landscape of macrophage-reprogramming cancer immunotherapies
Jenna H. Rannikko, Maija Hollmén
British Journal of Cancer (2024) Vol. 131, Iss. 4, pp. 627-640
Open Access | Times Cited: 18
Consensus, debate, and prospective on pancreatic cancer treatments
Junke Wang, Jie Yang, Amol Narang, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 18
Napabucasin deactivates STAT3 and promotes mitoxantrone-mediated cGAS-STING activation for hepatocellular carcinoma chemo-immunotherapy
Lingzhi Wang, Shengnan Bi, Zhuo Li, et al.
Biomaterials (2024) Vol. 313, pp. 122766-122766
Closed Access | Times Cited: 9
STING in Cancer Immunoediting: Modeling Tumor-Immune Dynamics Throughout Cancer Development
Xiao Zhang, Yan Chen, Xi Liu, et al.
Cancer Letters (2025) Vol. 612, pp. 217410-217410
Open Access | Times Cited: 1
Enhancing immunotherapy outcomes by targeted remodeling of the tumor microenvironment via combined cGAS-STING pathway strategies
Mingqing Huang, Zhuocen Cha, Rui Liu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 8
Discovery of Pyrido[2,3-d]pyrimidin-7-one Derivatives as Highly Potent and Efficacious Ectonucleotide Pyrophosphatase/Phosphodiesterase 1 (ENPP1) Inhibitors for Cancer Treatment
Yaoliang Sun, Man Chen, Yuyan Han, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 5, pp. 3986-4006
Closed Access | Times Cited: 5
Role of STING in the treatment of non-small cell lung cancer
Wenhua Tang, Wenjie Zhou, Mei Ji, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 5
In situ Non-canonical Activation and Sensitization of cGAS-STING Pathway with Manganese Telluride Nanosheets
Hongbo Gao, Yi Liu, Han Wang, et al.
Biomaterials (2025) Vol. 318, pp. 123170-123170
Closed Access
Albumin-targeted oxaliplatin(iv) prodrugs bearing STING agonists
Martijn Dijkstra, Michael Gutmann, Mathias Gradl, et al.
Inorganic Chemistry Frontiers (2025)
Open Access
The cGAS‒STING pathway in cancer immunity: mechanisms, challenges, and therapeutic implications
Mengzhou Shen, Xianjie Jiang, Peng Qiu, et al.
Journal of Hematology & Oncology (2025) Vol. 18, Iss. 1
Open Access
Unveiling the crossroads of STING signaling pathway and metabolic reprogramming: the multifaceted role of the STING in the TME and new prospects in cancer therapies
Siwei Wang, Qin Lu, Furong Liu, et al.
Cell Communication and Signaling (2025) Vol. 23, Iss. 1
Open Access
Carvedilol sensitizes chemotherapy by targeting STING to boost anti-tumor immunity
Yifang Dang, Mingtong Ma, Yan Wang, et al.
Cell Reports (2025) Vol. 44, Iss. 5, pp. 115572-115572
Closed Access
Chromone-Based Copper(II) Complexes as Potential Antitumour Agents: Synthesis, Chemical Characterisation and In Vitro Biological Evaluation
Nikolina Filipović, Tomislav Balić, Martina Medvidović‐Kosanović, et al.
Crystals (2025) Vol. 15, Iss. 5, pp. 389-389
Open Access
Make it STING: nanotechnological approaches for activating cGAS/STING as an immunomodulatory node in osteosarcoma
John O’Donoghue, Fiona E. Freeman
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Progress in nanomedicine for sonodynamic immunotherapy of tumors
Ziyan Feng, Ziyao Wang, Xi Xiang, et al.
Deleted Journal (2024) Vol. 1, Iss. 2, pp. 100027-100027
Open Access | Times Cited: 1
Roles of Water Molecules in STING Activation: A Computational Perspective
Hannah Gates, Rachel Payne, Haley Pfeifer, et al.
(2024)
Open Access | Times Cited: 1
Discovery of Orally Bioavailable Phosphonate Prodrugs of Potent ENPP1 Inhibitors for Cancer Treatment
Shanyun Gao, Yingjie Hou, Yanxiao Xu, et al.
European Journal of Medicinal Chemistry (2024) Vol. 279, pp. 116853-116853
Closed Access | Times Cited: 1
Targeting STING signaling for the optimal cancer immunotherapy
Yan Xu, Ying Xiong
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Lycorine Suppresses Non‐Small‐Cell Lung Cancer Progression Through Activating STING Pathway and Stimulating an Antitumor Immune Response
Zebo Jiang, Cong Xu, Pan Xu, et al.
Chemical Biology & Drug Design (2024) Vol. 104, Iss. 6
Closed Access | Times Cited: 1
Novel PARP7 Inhibitors for Treating Cancer
Ram W. Sabnis
ACS Medicinal Chemistry Letters (2023) Vol. 14, Iss. 12, pp. 1615-1616
Open Access | Times Cited: 3
At the Crossroads of the cGAS-cGAMP-STING Pathway and the DNA Damage Response: Implications for Cancer Progression and Treatment
Tatyana V. Korneenko, Nikolay B. Pestov, Ivan Nevzorov, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 12, pp. 1675-1675
Open Access | Times Cited: 3
Target interactions for macrophage regulation: toward the development of therapeutics for cancer and inflammatory diseases
Etsuko Toda, Yuya Terashima
Translational and Regulatory Sciences (2024) Vol. 6, Iss. 1, pp. 28-36
Open Access
THE STING AGONIST VB-85247 INDUCES DURABLE ANTITUMOR IMMUNE RESPONSES BY INTRAVESICAL ADMINISTRATION IN A NON-MUSCLE INVASIVE BLADDER CANCER
Miglena G. Prabagar, Michael S. McQueney, Venu Bommireddy, et al.
Cancer Research (2024)
Open Access
Page 1

Scroll to top